HIGHLIGHTS
- who: Proteogenomic integration reveals therapeutic and collaborators from the Department of Medicine, Washington University in StLouis, St. Louis, Missouri, USA. , McDonnell Genome Institute, Washington University in St. Louis have published the article: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts, in the Journal: NATURE COMMUNICATIONS NATURE COMMUNICATIONS of 28/03/2017
- what: The study demonstrates that MS-based proteomics can identify targets and highlights the potential of PDX drug response evaluation to annotate MS-based pathway activities. Of note, while iTRAQ and LFQ quantification were conducted separately and based on different features of the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.